WHO Prequalifies New Oral Polio Vaccine nOPV2

 



The World Health Organization (WHO) has prequalified another novel oral polio vaccine type 2 (nOPV2), strengthening global efforts to eradicate poliomyelitis. The decision enables United Nations agencies, including UNICEF, to procure and distribute the vaccine for immunisation campaigns worldwide.

Prequalification confirms that the vaccine meets international standards of quality, safety and efficacy, facilitating its use in large-scale public health programmes.

Why nOPV2 Matters

The nOPV2 vaccine has been engineered to be more genetically stable than earlier oral polio vaccines. Traditional oral vaccines, while effective, carried a rare risk of mutating and triggering circulating vaccine-derived poliovirus outbreaks.

By enhancing genetic stability, nOPV2 lowers the likelihood of such reversions while maintaining the ability to interrupt virus transmission. This innovation addresses a key challenge in the final stages of global polio eradication.

Global Eradication Push

The prequalification follows a December pledge by global leaders to mobilise $1.9 billion in funding to accelerate eradication efforts. The programme aims to immunise approximately 370 million children annually, even amid fiscal constraints and competing health priorities.

Polio has been eliminated from most parts of the world through sustained vaccination drives. However, the virus continues to circulate in limited regions, posing risks of resurgence if immunisation coverage declines.

Continuing Public Health Challenge

Poliomyelitis is a highly infectious viral disease that can cause paralysis and, in severe cases, death. It primarily affects children under five years of age. Global eradication efforts, led by WHO and partners, rely heavily on oral polio vaccines for mass campaigns due to their ease of administration and ability to induce intestinal immunity.

Towards a Polio-Free World

The approval of another nOPV2 vaccine represents a critical step in closing immunity gaps and preventing vaccine-derived outbreaks. With sustained funding and high immunisation coverage, global health agencies seek to eliminate the remaining pockets of poliovirus transmission and secure a polio-free future.

#Vaccines
#Immunization
#Vaccination
#PublicHealth
#GlobalHealth
#PreventiveMedicine
#InfectiousDiseases
#VaccineResearch
#DiseasePrevention
#VaccinesWork


World Cell Biologist Awards: 

Website Link : cellbiologist.org 

Follow Us On : 
Tumblr ; tumblr.ccom/

Comments

Post a Comment

Popular posts from this blog

Uttrakhand Forest Department Establishes Mahabharata Vatika

Image
  The Uttarakhand Forest Department has established two gardens in Haldwani, showcasing plant species referenced in ancient Indian epics. These gardens, named Ramayana Vatika and Mahabharata Vatika, aim to highlight the ecological wisdom embedded in these texts. Mahabharata Vatika Overview Mahabharata Vatika spans one acre and features 37 plant species mentioned in the epic. Chief Conservator of Forests Sanjeev Chaturvedi emphasised the research behind selecting these species. The garden features important plant species such as: Ecological Significance The garden puts stress on the importance of forests as depicted in the Mahabharata. It references the Vana Parva, which discusses tree planting and wildlife conservation . The epic highlights the mutual dependence of tigers and forests, a concept vital to contemporary conservation efforts. Cultural Connections Chaturvedi brought into light that the Mahabharata teaches the spiritual significance of planting trees. He mentioned Bhish...
Read more

CAR T-Cell Therapy for Cancer

Image
  India has recently made strides in cancer treatment with the introduction of CAR T-cell therapy . The results from the first clinical trials have been published in The Lancet, showcasing a remarkable success rate. This therapy is a game changer for patients with blood cancers. It offers hope to those who have exhausted other treatment options. What is CAR T-Cell Therapy? CAR T-cell therapy, or chimeric antigen receptor T-cell therapy, is an innovative treatment that harnesses the body’s immune system. It trains T-cells to target and destroy cancer cells. This therapy is specifically designed for certain blood cancers. It is particularly beneficial for patients whose cancer has relapsed or failed to respond to standard treatments. Clinical Trial The clinical trials reported a response rate of nearly 73%. This indicates that number of patients benefited from the treatment. The trials also provided critical data on survival rates for patients with acute lymphoblastic leukaemia and l...
Read more

New Turmeric Cousin Discovered in Nagaland’s Ungma Village

Image
  During a field trip to Nagaland, researchers found a new species of plant closely related to turmeric. This new species, named Curcuma ungmensis, was discovered near the village of Ungma and has now been published in the scientific journal Phytotaxa. Taxonomy and Family Curcuma ungmensis belongs to the Curcuma genus, which is part of the ginger family, known scientifically as Zingiberaceae. This family includes about 200 species in India, such as the well-known turmeric (Curcuma longa) and black turmeric (Curcuma caesia). Plants in this genus are mainly found in South and Southeast Asia. How was the New Species Identified? Researchers carefully studied all known species of Curcuma in the region. When they couldn’t find any matches in the Checklist of Flora of Nagaland published by the Botanical Survey of India, they concluded that they had discovered a completely new species. Botanical Characteristics Curcuma ungmensis is a rhizomatous herb, meaning it grows from underground ste...
Read more